In conclusion, the results indicate that this type of nACP justifies developing a strategy for its potential use as an anti-cancer agent and/or as a possible anti-cancer active carrier for various drugs in oral cancer treatments. Here, SNCA is linked to lip and oral cavity carcinoma.